Santoro, N. et al. The menopause transition: signs, symptoms, and management options. J. Clin. Endocrinol. Metab. 106, 1–15 (2021).

Article  PubMed  Google Scholar 

Santoro, N. The menopausal transition. Am. J. Med. 118, 8–13 (2005).

Article  PubMed  Google Scholar 

Harlow, S. D. et al. Executive summary of the stages of reproductive aging workshop+10: addressing the unfinished agenda of staging reproductive aging. Menopause 19, 387–395 (2012).

Article  PubMed  PubMed Central  Google Scholar 

Paramsothy, P. et al. Duration of the menopausal transition is longer in women with young age at onset: the multiethnic study of Women’s health across the nation. Menopause 24, 142–149 (2017).

Article  PubMed  PubMed Central  Google Scholar 

Klein, N. A. et al. Is the short follicular phase in older women secondary to advanced or accelerated dominant follicle development? J. Clin. Endocrinol. Metab. 87, 5746–5750 (2002).

Article  CAS  PubMed  Google Scholar 

Van Voorhis, B. J. et al. The relationship of bleeding patterns to daily reproductive hormones in women approaching menopause. Obstet. Gynecol. 112, 101–108 (2008).

Article  PubMed  PubMed Central  Google Scholar 

Randolph, J. F. Jr. et al. Change in follicle-stimulating hormone and estradiol across the menopausal transition: effect of age at the final menstrual period. J. Clin. Endocrinol. Metab. 96, 746–754 (2011).

Article  CAS  PubMed  Google Scholar 

Harlow, S. D. et al. STRAW+10 collaborative group. executive summary of the stages of reproductive aging workshop+10: addressing the unfinished agenda of staging reproductive aging. J. Clin. Endocrinol. Metab. 97, 1159–1168 (2012).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Col, N. F. et al. Duration of vasomotor symptoms in middle-aged women: a longitudinal study. Menopause 16, 453–457 (2009).

Article  PubMed  Google Scholar 

Politi, M. C., Schleinitz, M. D. & Col, N. F. Revisiting the duration of vasomotor symptoms of menopause: a meta-analysis. J. Gen. Intern. Med. 23, 1507–1513 (2008).

Article  PubMed  PubMed Central  Google Scholar 

El Khoudary, S. R. & Thurston, R. C. Cardiovascular implications of the menopause transition: endogenous sex hormones and vasomotor symptoms. Obstet. Gynecol. Clin. North. Am. 45, 641–661 (2018).

Article  PubMed  Google Scholar 

Portman, D. J., Gass, M. L. & Vulvovaginal Atrophy Terminology Consensus Conference Panel. Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International society for the study of women’s sexual health and the North American menopause society. Menopause 21, 1063–1068 (2014).

Article  PubMed  Google Scholar 

Levine, K. B., Williams, R. E. & Hartmann, K. E. Vulvovaginal atrophy is strongly associated with female sexual dysfunction among sexually active postmenopausal women. Menopause 151, 661–666 (2008).

Article  Google Scholar 

Bromberger, J. T. et al. Major depression during and after the menopausal transition: study of women’s health across the nation (SWAN). Psychol. Med. 41, 1879–1888 (2011).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Soares, C. N. Depression in peri- and postmenopausal women: prevalence, pathophysiology and pharmacological management. Drugs Aging 30, 677–685 (2013).

Article  CAS  PubMed  Google Scholar 

Kravitz, H. M. et al. Sleep difficulty in women at midlife: a community survey of sleep and the menopausal transition. Menopause 10, 19–28 (2003).

PubMed  Google Scholar 

Leiblum, S. R. et al. Hypoactive sexual desire disorder in postmenopausal women: US results from the women’s international study of health and sexuality (WISHeS). Menopause 13, 46–56 (2006).

Article  PubMed  Google Scholar 

Cosman, F. et al. National Osteoporosis Foundation. Clinician’s guide to prevention and treatment of osteoporosis. Osteoporos. Int. 25, 2359–2381 (2014).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pinkerton, J. V., Komm, B. S. & Mirkin, S. Tissue selective estrogen complex combinations with bazedoxifene/conjugated estrogens as a model. Climacteric 16, 618–628 (2013).

Article  CAS  PubMed  Google Scholar 

Karlamangla, A. S., Burnett-Bowie, S.-A. & Crandall, C. J. Bone health during the menopause transition and beyond. Obstet. Gynecol. Clin. North. Am. 45, 695–708 (2018).

Article  PubMed  PubMed Central  Google Scholar 

Polo-Kantola, P. et al. Effect of short-term transdermal estrogen replacement therapy on sleep: a randomized, double-blind crossover trial in postmenopausal women. Fertil. Steril. 71, 873–880 (1999).

Article  CAS  PubMed  Google Scholar 

Stuenkel, C. A. et al. Treatment of symptoms of the menopause: an endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 100, 3975–4011 (2015).

Article  CAS  PubMed  Google Scholar 

Santen, R. J. et al. Postmenopausal hormone therapy: an Endocrine Society scientific statement. J. Clin. Endocrinol. Metab. 95, s1–s66 (2010).

Article  CAS  PubMed  PubMed Central  Google Scholar 

[No authors listed]. Effects of hormone replacement therapy on endometrial histology in postmenopausal women. The postmenopausal estrogen/progestin interventions (PEPI) trial. The Writing Group for the PEPI Trial. JAMA 275, 370–375 (1996).

Weber, L. & Thacker, H. L. Paroxetine: a first for selective serotonin reuptake inhibitors — a new use. Approved for vasomotor symptoms in postmenopausal women. Womens Health 10, 147–154 (2014).

CAS  Google Scholar 

The North American Menopause Society. The 2023 nonhormone therapy position statement of the North American menopause society. Menopause 30, 573–590 (2023).

Article  Google Scholar 

Menown, S. J. & Tello, J. A. Neurokinin 3 receptor antagonists compared with serotonin norepinephrine reuptake inhibitors for non-hormonal treatment of menopausal hot flushes: a systematic qualitative review. Adv. Ther. 38, 5025–5045 (2021).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rance, N. E., Dacks, P. A., Mittelman-Smith, M. A., Romanovsky, A. A. & Krajewski-Hall, S. J. Modulation of body temperature and LH secretion by hypothalamic KNDy (kisspeptin, neurokinin B and dynorphin) neurons: a novel hypothesis on the mechanism of hot flushes. Front. Neuroendocrinol. 34, 211–227 (2013).

Article  CAS  PubMed  Google Scholar 

Onge, E. S., Phillips, B. & Miller, L. Fezolinetant: a new nonhormonal treatment for vasomotor symptoms. J. Pharm. Technol. 39, 291–297 (2023).

Article  PubMed  PubMed Central  Google Scholar 

Cieri-Hutcherson, N. E. et al. Systematic review of neurokinin-3 receptor antagonists for the management of vasomotor symptoms of menopause. Menopause 31, 342–354 (2024).

Article  PubMed  Google Scholar 

Newton, K. M. et al. Treatment of vasomotor symptoms of menopause with black cohosh, multibotanicals, soy, hormone therapy, or placebo: a randomized trial. Ann. Intern. Med. 145, 869–879 (2006).

Article  PubMed  Google Scholar 

Shah, S. et al. E2 and not P4 increases NO release from NANC nerves of the gastrointestinal tract: implications in pregnancy. Am. J. Physiol. Regul. Integr. Comp. Physiol. 280, R1546–R1554 (2001).

Article  CAS  PubMed  Google Scholar 

Bradesi, S. et al. Effect of ovarian hormones on intestinal mast cell reactivity to substance P. Life Sci. 68, 1047–1056 (2001).

Article  CAS  PubMed  Google Scholar 

Zia, J. K. & Heitkemper, M. M. Upper gastrointestinal tract motility disorders in women, gastroparesis, and gastroesophageal reflux disease. Gastroenterol. Clin. North Am. 45, 239–251 (2016).